Dorantes SM, Bazán MM

Language: Spanish
References: 16
Page: 146-152
PDF size: 731.58 Kb.

ABSTRACT

Ventricular depolarization and repolarization processes are discussed, including their differences and heterogeneity both in patients with a healthy/sick heart, a matter of ranges. Measurements expressing the characteristics of ventricular repolarization are analyzed: the QT interval and other even more reliable measurements such as the TPEAK-TEND interval, its dispersion and others. We emphasize on the existence of the long QT syndrome (and sign) and the three basic processes of arrhythmogenesis: heterogeneity, alternation and dispersion, with differences in action potentials in the three zones of the ventricular myocardium. The risk factors of long QT (common in this therapy) and ventricular arrhythmias (especially torsades de pointes, extremely rare in these cases) are highlighted. The need to assess clinical and electrical features, comorbidities, aggregate conflicts, and management of these patients is also discussed.

REFERENCES

1. Antzelevitch C. Cardiac repolarization. The long and short of it. Europace. 2005;7(Supl 2):3-9. [ Links ]

2. Viskin S. The QT interval: too long, too short or just right. Heart Rhythm. 2009;6(5):711-5. [ Links ]

3. Parvez B, Darbar D. Novel ECG markers for ventricular repolarization: is the QT interval obsolete? Heart Rhythm . 2011;8(7):1044-5. [ Links ]

4. Morita H, Wu J, Zipes DP. The QT syndromes: long and short. Lancet. 2008;372(9640):750-63. [ Links ]

5. Verrier RL, Huikuri H. Tracking interlead heterogeneity of R-and T-wave morphology to disclose latent risk for sudden cardiac death. Heart Rhythm. 2017;14(10):1466-75. [ Links ]

6. Kentta TV, Nearing BD, Porthan K, Tikkanen JT, Vitasalo M, Nieminen MS, et al. Prediction of sudden cardiac death with automated high-throughput analysis of heterogeneity in standard resting 12-lead electrocardiograms. Heart Rhythm. 2016;13(3):713-20. [ Links ]

7. Shimizu W. Where does heterogeneity exist in ventricular tachyarrhythmias? Heart Rhythm . 2015;12(6):1304-5. [ Links ]

8. Coronel R, Wilms-Schopman FJ, Opthof T, Janse MJ. Dispersion of repolarization and arrhythmogenesis. Heart Rhythm. 2009;6(4):537-43. [ Links ]

9. Kirchhof P, Franz MR, Bardai A, Wilde AM. Giant T-U waves precede torsades de pointes in long QT syndrome. A systematic electrocardiographic analysis in patient with acquired and congenital QT prolongation. J Am Coll Cardiol. 2009;54(2):143-9. [ Links ]

10. El-Sherif N, Turitto G, Boutjdir M. Acquired long QT syndrome and torsade de pointes. Pacing Clin Electrophysiol. 2018;41(4):414-21. [ Links ]

11. Laksman ZW, Krahn AD. Fast and spurious: correcting the QT interval. Heart Rhythm. 2016;13(2):536-7. [ Links ]

12. Khakpour H, Vaseghi M. Electrocardiographic Tpeak to Tend interval: the short and long of it. Heart Rhythm. 2016;13(4):925-6. [ Links ]

13. Tse G, Gong M, Wong WT, Georgopoulos S, Letsas KP, Vassiliou VS, et al. The Tpeak-Tend interval as an electrocardiographic risk marker of arrhythmic and mortality outcomes: a systematic review and meta-analysis. Heart Rhythm. 2017;14(8):1131-7. [ Links ]

14. Porta-Sánchez A, Gilbert C, Spears D, Amir E, Chan J, Nanthakumar K, et al. Incidence, diagnosis, and management of QT prolongation induced by cancer therapies: a systematic review. J Am Heart Assoc [Internet]. 2017[citado 28/12/2018];6(12):e007724. Disponible en: Disponible en: https://www.ahajournals.org/doi/pdf/10.1161/JAHA.117.007724 [ Links ]

15. Coppola C, Rienzo A, Piscopo G, Barbieri A, Arra C, Maurea N. Management of QT prolongation induced by anti-cancer drugs: target therapy and old agents. Different algorithms for different drugs. Cancer Treat Rev. 2018;63:135-43. [ Links ]

16. Buza V, Rajagopalau B, Curtis AB. Cancer treatment-induced arrhythmias focus on chemotherapy and targeted therapies. Circ Arrhythm Electrophysiol[Internet]. 2017 [citado 5/01/2019];10(8):e005443. Disponible en: Disponible en: https://www.ahajournals.org/doi/pdf/10.1161/CIRCEP.117.005443 [ Links ]